Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA (DWRKF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dwrkf · pe ratio · data through Jun 8, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Drägerwerk AG & Co. KGaAYou DWRKF | $1.8B | 11.02x | -69.7% | $8.16 |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | -77.6% | $231.09 |
 Biotest AG BIESF | $1.6B | 41.48x | +14.1% | $0.71 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +27.2% | $3.55 |
 CompuGroup Medical SE & Co. KGaA CMPUY | $1.2B | 33.34x | -8.2% | $0.67 |
 CompuGroup Medical SE & Co. KGaA CMPVF | $1.7B | 52.49x | +44.5% | $0.55 |
 Karo Pharma AB (publ) KARBF | $1.5B | N/A | — | — |
Industry Average 5 peers with valid PE | — | 36.34x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DWRKF) measures how much investors pay for each dollar of the company's trailing earnings. DWRKF's current PE ratio of 11.02x is calculated by dividing its stock price of $543.70 by its TTM earnings per share of $8.16.
Frequently asked questions
DWRKF pe ratio · 6 questionsDWRKF's current PE ratio is 11.02x as of 2026-06-08, based on a stock price of $543.70 and TTM EPS of $8.16. Data sourced from Financial Modeling Prep via DWRKF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Drägerwerk AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08